Add time:08/11/2019 Source:sciencedirect.com
In finding that 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (BPHPP) produced high concentrations of blood glucose in rats, it was observed that (1) the maximum concentration of blood glucose was obtained 1 hr after oral administration at a dose of 100 mg/kg of BPHPP, (2) that BPHPP has no effect on the secretion of adrenal corticosterone, (3) that BPHPP markedly inhibited cAMP phosphodiesterase activity, in vitro, and (4) that in the preliminary experiment, the hepatic cAMP levels increased 1.7-fold by the administration (10 mg/kg) of BPHPP.From these results, it was presumed that the high concentrations of blood glucose may be the results of elevations in the intracellular cAMP levels due to the inhibitory action of BPHPP on cAMP phosphodiesterase.
We also recommend Trading Suppliers and Manufacturers of 1-(2-Hydroxyphenyl)-3-(piperidino)-2-propene-1-one (cas 1084-62-4). Pls Click Website Link as below: cas 1084-62-4 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View